May Edition Vol. II - 2026

May Edition Vol. II - 2026

India Pharma Outlook’s May Edition Vol. II - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribu­tion to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.

We aspire to become part of a unified healthcare platform where medicines, devices, diagnostics, and technology come together under one roof. That vision, grounded in science and executed with intent, positions 9M Lifesciences as a company to watch in India’s evolving healthcare landscape. - 9M Lifesciences

Bhasin Group is focused on expanding its role in turnkey healthcare solutions, where hospitals increasingly prefer a single partner to manage comprehensive supply needs. - Bhasin Group

By maintaining structured relationships with these partners, supported by financial safeguards and regular reconcilia­tions, Gesun ensures operational efficiency and accountability across its distribution chain. - Gesun Lifesciences

Knowell Pharma Solutions addresses these challenges through a proactive and collaborative approach. The company...

Avishek Dasgupta,Managing Partner

Avishek Dasgupta

Managing Partner

May Edition Vol. II - 2026

Gesun Lifesciences Gesun Lifesciences Gesun Lifesciences The antibiotic distribution landscape in India has evolved into a highly complex and strategically critical segment within the broader pharmaceutical ecosystem.

© 2026 India Pharma Outlook. All Rights Reserved.